684 related articles for article (PubMed ID: 26501105)
1. The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study.
Hosomi N; Nagai Y; Kohriyama T; Ohtsuki T; Aoki S; Nezu T; Maruyama H; Sunami N; Yokota C; Kitagawa K; Terayama Y; Takagi M; Ibayashi S; Nakamura M; Origasa H; Fukushima M; Mori E; Minematsu K; Uchiyama S; Shinohara Y; Yamaguchi T; Matsumoto M;
EBioMedicine; 2015 Sep; 2(9):1071-8. PubMed ID: 26501105
[TBL] [Abstract][Full Text] [Related]
2. Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event.
Hosomi N; Nagai Y; Kitagawa K; Nakagawa Y; Aoki S; Nezu T; Kagimura T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Matsumoto M;
J Atheroscler Thromb; 2018 Mar; 25(3):262-268. PubMed ID: 28924103
[TBL] [Abstract][Full Text] [Related]
3. Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke).
Hosomi N; Kitagawa K; Nagai Y; Nakagawa Y; Aoki S; Nezu T; Kagimura T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Matsumoto M;
Stroke; 2018 Apr; 49(4):865-871. PubMed ID: 29511130
[TBL] [Abstract][Full Text] [Related]
4. Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS.
Kitagawa K; Hosomi N; Nagai Y; Kagimura T; Ohtsuki T; Origasa H; Minematsu K; Uchiyama S; Nakamura M; Matsumoto M;
J Atheroscler Thromb; 2017 Oct; 24(10):1039-1047. PubMed ID: 28302952
[TBL] [Abstract][Full Text] [Related]
5. Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS).
Nagai Y; Kohriyama T; Origasa H; Minematsu K; Yokota C; Uchiyama S; Ibayashi S; Terayama Y; Takagi M; Kitagawa K; Nomura E; Hosomi N; Ohtsuki T; Yamawaki T; Matsubara Y; Nakamura M; Yamasaki Y; Mori E; Fukushima M; Kobayashi S; Shinohara Y; Yamaguchi T; Matsumoto M;
Int J Stroke; 2014 Feb; 9(2):232-9. PubMed ID: 24015915
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Effect of Pravastatin on Carotid Intima-Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke).
Koga M; Toyoda K; Minematsu K; Yasaka M; Nagai Y; Aoki S; Nezu T; Hosomi N; Kagimura T; Origasa H; Kamiyama K; Suzuki R; Ohtsuki T; Maruyama H; Kitagawa K; Uchiyama S; Matsumoto M;
Stroke; 2018 Jan; 49(1):107-113. PubMed ID: 29191850
[TBL] [Abstract][Full Text] [Related]
7. Different Influences of Statin Treatment in Preventing At-Risk Stroke Subtypes: A Post Hoc Analysis of J-STARS.
Hosomi N; Kitagawa K; Nagai Y; Nakagawa Y; Aoki S; Nezu T; Kagimura T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Matsumoto M;
J Atheroscler Thromb; 2020 May; 27(5):449-460. PubMed ID: 31534062
[TBL] [Abstract][Full Text] [Related]
8. Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA.
Kitagawa K; Hosomi N; Nagai Y; Kagimura T; Ohtsuki T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Nakamura M; Matsumoto M;
J Atheroscler Thromb; 2019 May; 26(5):432-441. PubMed ID: 30318492
[TBL] [Abstract][Full Text] [Related]
9. The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study: Rationale and Trial Protocol.
Toyoda K; Minematsu K; Yasaka M; Nagai Y; Hosomi N; Origasa H; Kitagawa K; Uchiyama S; Koga M; Matsumoto M;
J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):595-599. PubMed ID: 28010953
[TBL] [Abstract][Full Text] [Related]
10. Effect of Statin on Stroke Recurrence Prevention at Different Infarction Locations: A Post Hoc Analysis of The J-STARS Study.
Nezu T; Hosomi N; Kitagawa K; Nagai Y; Nakagawa Y; Aoki S; Kagimura T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Matsumoto M;
J Atheroscler Thromb; 2020 Jun; 27(6):524-533. PubMed ID: 31554765
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.
Amarenco P; Kim JS; Labreuche J; Charles H; Abtan J; Béjot Y; Cabrejo L; Cha JK; Ducrocq G; Giroud M; Guidoux C; Hobeanu C; Kim YJ; Lapergue B; Lavallée PC; Lee BC; Lee KB; Leys D; Mahagne MH; Meseguer E; Nighoghossian N; Pico F; Samson Y; Sibon I; Steg PG; Sung SM; Touboul PJ; Touzé E; Varenne O; Vicaut É; Yelles N; Bruckert E;
N Engl J Med; 2020 Jan; 382(1):9. PubMed ID: 31738483
[TBL] [Abstract][Full Text] [Related]
12. Baseline Carotid Intima-Media Thickness and Stroke Recurrence During Secondary Prevention With Pravastatin.
Wada S; Koga M; Minematsu K; Toyoda K; Suzuki R; Kagimura T; Nagai Y; Aoki S; Nezu T; Hosomi N; Origasa H; Ohtsuki T; Maruyama H; Yasaka M; Kitagawa K; Uchiyama S; Matsumoto M
Stroke; 2019 Jun; 50(6):1586-1589. PubMed ID: 31035902
[TBL] [Abstract][Full Text] [Related]
13. Medium-intensity statin with ezetimibe versus high-intensity statin in acute ischemic cerebrovascular disease (MESIA): A randomized clinical trial.
Lv X; Liu X; Peng Y; Li W; Wang J; Chen X; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L
J Stroke Cerebrovasc Dis; 2024 May; 33(5):107647. PubMed ID: 38431112
[TBL] [Abstract][Full Text] [Related]
14. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.
Plehn JF; Davis BR; Sacks FM; Rouleau JL; Pfeffer MA; Bernstein V; Cuddy TE; Moyé LA; Piller LB; Rutherford J; Simpson LM; Braunwald E
Circulation; 1999 Jan; 99(2):216-23. PubMed ID: 9892586
[TBL] [Abstract][Full Text] [Related]
15. Statins and the risks of stroke recurrence and death after ischemic stroke: the Fukuoka Stroke Registry.
Makihara N; Kamouchi M; Hata J; Matsuo R; Ago T; Kuroda J; Kuwashiro T; Sugimori H; Kitazono T;
Atherosclerosis; 2013 Dec; 231(2):211-5. PubMed ID: 24267228
[TBL] [Abstract][Full Text] [Related]
16. Assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction – ALPS-AMI study.
Izawa A; Kashima Y; Miura T; Ebisawa S; Kitabayashi H; Yamamoto H; Sakurai S; Kagoshima M; Tomita T; Miyashita Y; Koyama J; Ikeda U;
Circ J; 2015; 79(1):161-8. PubMed ID: 25392071
[TBL] [Abstract][Full Text] [Related]
17. [J-STARS (Japan statin treatment against recurrent stroke)].
Kohriyama T; Nomura E; Matsumoto M; Ohtsuki T
Nihon Rinsho; 2006 Oct; 64 Suppl 7():511-8. PubMed ID: 17461197
[No Abstract] [Full Text] [Related]
18. Statin treatment after a recent TIA or stroke: is effectiveness shown in randomized clinical trials also observed in everyday clinical practice?
Lingsma HF; Steyerberg EW; Scholte op Reimer WJ; van Domburg R; Dippel DW;
Acta Neurol Scand; 2010 Jul; 122(1):15-20. PubMed ID: 20047571
[TBL] [Abstract][Full Text] [Related]
19. Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack.
Byun YS; Yang X; Bao W; DeMicco D; Laskey R; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2017 Jan; 69(2):147-158. PubMed ID: 28081824
[TBL] [Abstract][Full Text] [Related]
20. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
